Economic Impact of AIM


Despite a lengthy period of uncertainty and turmoil, intensified by the Covid-19 pandemic, AIM remains instrumental in fostering business growth, thereby contributing significant economic value to the UK.

This Grant Thornton report, commissioned by Criticaleye Partner London Stock Exchange Group is the first piece of analysis on AIM that has been carried out since June 2020.

Key takeaways include:

  • In 2023, AIM companies contributed £35.7 billion Gross Value Added (GVA) to UK GDP and directly supported more than 410,000 jobs.
  • The aggregate overseas turnover for AIM companies has continued to grow from £12.7 billion in 2019 to £17.6 billion in 2023.
  • 58 percent of AIM companies have at least one woman in a Board position, 23 percent have a female CFO and 5 percent have a female CEO.

 


Share this with your Community





Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


How to Execute a Successful Exit with Paul Lester CBE

A successful exit is rarely defined by valuation alone. Behind every strong outcome is strategic preparation, disciplined leadership and an organisation that is ready for transition. In this episode of Criticaley...


Click here to download this insight

BLOG | The CEO-CFO Partnership: Driving Strategic Alignment

The relationship between the CEO and CFO has never been more important.  In a business environment defined by economic uncertainty, AI-driven transformation and heightened stakeholder expe...


Click here to download this insight

Building an AI-Ready Workforce

AI is reshaping ways of working faster than most organisations can adapt, putting talent strategy at the top of the Board agenda. Criticaleye's Anna Mitchell asks Board Leaders and CPOs with hands-on experience o...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 177




Rolls-Royce Global Payments AlixPartners NatWest Group Stream Mayborn Group NATS Lightsource bp E.ON UK British Land Hitachi Solutions Legal & General London Stock Exchange Group LACE Partners Drax Group plc GlaxoSmithKline plc